An Australian stem cell and regenerative medicine company

November 20, 2020

Interview with Ross Macdonald

Stuart Roberts, respected analyst and industry commentator at Pitt Street Research speaks with Dr Ross Macdonald about Cynata's market position, research and clinical trials.

Interview with Dr Ross MacDonald, CEO Cynata Therapeutics (ASX:CYP) 20 November 2020 from Pitt Street Research on Vimeo.